1. School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China; 2. China Medical University, Shenyang 110001,China; 3. Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
Abstract��OBJECTIVE To explore the anti-osteoporotic mechanism of icariin based on osteoblast and osteoclast proteomics. METHODS The cell proliferation was determined by MTT assay. The activity of alkaline phosphatase (ALP) in osteoblasts and tartrate-resistant acid phosphatase (TRAP) in osteoclast were measured using ELISA kit. Alizarin red staining was used to observe the formation of bone mineralized nodules in osteoblasts. The number and area of bone resorption pit formed on bone slices by osteoclasts were used to characterize the activity of osteoclastic bone resorption. Two-dimensional gel electrophoresis was used to observe the changes of icariin-treated osteoblast and osteoclast proteomics. TOF/MS/MS analysis was applied to identify the differentially expressed proteins. RESULTS Icariin significantly enhanced the osteoblastic bone formation and inhibited the osteoclastic bone resorption, and up-regulated or down-regulated expression of nine proteins in osteoblast and osteoclast, respectively. CONCLUSION Icariin regulates bone metabolism through involving multiple biological process, including energy metabolism, oxidative stress, purine synthesis and cell growth and differentiation.
ZHANG H W, REEKER R, LEE W P, et al. Proteomies in bone research. Expeat Rev Proteomics, 2010, 7(1): 103-111.
[2]
WANG T, HU J, HAN L. Preclinical pharmacodynamic evaluation of new chinese drugs for osteoporosis. China J Chin Mater Med(�й���ҩ��־), 2006, 31(19): 1655-1656.
[3]
WANG Z, WANG D, YANG D, et al. The effect of icariin on bone metabolism and its potential clinical application. Osteoporos Int, 2018, 29(3):535-544.
[4]
CHEN M, HAO J, YANG Q, et al. Effects of icariin on reproductive functions in male rats. Molecules, 2014, 19(7):9502-9514.
[5]
LI C R, LI Q, MEI Q B,et al. Pharmacological effects and pharmacokinetic properties of icariin,the major bioactive component in Herba Epimedii. Life Sci, 2015,126:57-68.
[6]
ANNA M, MAGDA G I, UMBERTO T, et al. Effects of microgravity onosteoblast mitochondria: aproteomic and metabolomics profile. Sci Reports, 2017,7(1):15376. DOI:10.1038/s41598-017-15612-1.
[7]
MARTIAL B D, GABRIEL C S, SUZANNE F, et al. The last Enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the golgi/endosomes protein network. Mol Cell Proteomics, 2015, 14(4):1079-1092.
[8]
ANDREI M M, SVETLANA A M, ZHANG Y N, et al. CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter. Nucleic Acids Res, 2000, 28(19):3762-3770.
[9]
LIU J, ZHANG S C, LI L. A transferrin-like homolog in amphioxus Branchiostoma belcheri: identification, expression and functional characterization. Mol Immunol, 2009,46(15): 3117-3124.
[10]
DU J, FENG W, SUN J. Ovariectomy upregulated the expression of peroxiredoxin 1 & 5 in osteoblasts of mice. Sci Reports,2016,6:35995. DOI: 10.1038/srep35995.
[11]
GIOVANNA L, ASMA N. Annexin A1: shifting the balance towards resolution and repair. Biol Chem, 2016, 397(10): 971-979.
[12]
GABRIELA P P, KARINA R L, DIEGO B, et al. Systems biology approach reveals possible evolutionarily conserved moonlighting functions for enolase. Comput Biol Chem, 2015, 58:1-8.
[13]
WU D, WU Z D, YU X B. Advance in the research of phosphoglycerate kinase. China Tropic Med (�й��ȴ�ҽѧ), 2005, 5(2): 385-388.
[14]
PAUL A P, JEFFERY M C, MATTHEW K W. Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. J Bone Miner Res, 2002, 17(7):1171-1179.
[15]
WANG W T, LI J Y. HSPA5 research progress. Chin Foreign Med Res(����ҽѧ�о�), 2010, 8(8): 26-29.
[16]
ALESSANDRO M, LUIGIA D F, ACHILLE I, et al. The interplay between peroxiredoxin-2 and nuclear factor-erythroid 2 is important in limiting oxidative mediated dysfunction in ��-thalassemic erythropoiesis. Antioxid Redox Signal, 2015,23(16):1284-1297.